Stocks · Health care · Surgical & Medical Instruments & Apparatus

Beta Bionics, Inc.

BBNX Clue Score57
United States Fiscal year ends December CIK 0001674632 Results filed 27 Oct 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
Mark Hopman
2 Nov 2026
Chief Commercial Officer
Sold on a plan
370
$16.90
$6.25K
Mike Mensinger
27 Oct 2026
Chief Product Officer
Sold on a plan
2,650
$22.00
$58.30K
Mark Hopman
26 Oct 2026
Chief Commercial Officer
Sold on a plan
821
$20.00
$16.42K
Mark Hopman
14 Oct 2026
Chief Commercial Officer
Sell
775
$17.35
$13.45K
Mark Hopman
1 Oct 2026
Chief Commercial Officer
Sell
370
$18.96
$7.02K
Christy Jones
22 Sep 2026
Director
Sold on a plan
6,430
$23.00
$147.89K
Mike Mensinger
16 Sep 2026
Chief Product Officer
Sold on a plan
2,650
$22.00
$58.30K
Mark Hopman
16 Sep 2026
Chief Commercial Officer
Sold on a plan
30,779
$20.13
$619.64K
Mark Hopman
14 Sep 2026
Chief Commercial Officer
Sold on a plan
775
$15.52
$12.03K
Mark Hopman
9 Sep 2026
Chief Commercial Officer
Sold on a plan
36,870
$18.46
$680.72K
Sean Saint
3 Sep 2026
President & CEO
Sold on a plan
5,641
$20.08
$113.26K
Sean Saint
2 Sep 2026
President & CEO
Sell
16,867
$19.11
$322.38K
Stephen Feider
2 Sep 2026
Chief Financial Officer
Sell
6,675
$19.11
$127.58K
Mike Mensinger
2 Sep 2026
Chief Product Officer
Sell
4,375
$19.11
$83.62K
Steven Jon Russell
2 Sep 2026
Chief Medical Officer
Sell
4,221
$19.11
$80.68K
Mark Hopman
2 Sep 2026
Chief Commercial Officer
Sell
5,327
$19.11
$101.82K
Stephen Feider
29 Jun 2026
Chief Financial Officer
Sold after exercise
4,896
$17.03
$83.38K
Stephen Feider
26 Jun 2026
Chief Financial Officer
Sold after exercise
5,104
$17.05
$87.01K
Christy Jones
24 Jun 2026
Director
Sold on a plan
1,406
$15.00
$21.09K
Mark Hopman
24 Jun 2026
Chief Commercial Officer
Sold on a plan
1,258
$15.01
$18.88K
Christy Jones
4 Jun 2026
Director
Sold on a plan
2,811
$14.00
$39.35K
Mark Hopman
4 Jun 2026
Chief Commercial Officer
Sold on a plan
275
$12.31
$3.39K
Sean Saint
2 Jun 2026
President & CEO
Sell
16,872
$12.61
$212.71K
Stephen Feider
2 Jun 2026
Chief Financial Officer
Sell
6,676
$12.61
$84.16K
Steven Jon Russell
2 Jun 2026
Chief Medical Officer
Sell
4,222
$12.61
$53.23K
Mark Hopman
2 Jun 2026
Chief Commercial Officer
Sell
5,329
$12.61
$67.18K
Mike Mensinger
2 Jun 2026
Chief Product Officer
Sell
4,378
$12.61
$55.19K
Adam Lezack
22 May 2026
Director
Sold on a plan
998
$11.21
$11.19K
Adam Lezack
21 May 2026
Director
Sold on a plan
1,000
$9.95
$9.95K
Christy Jones
21 May 2026
Director
Sold on a plan
1,998
$9.95
$19.88K
Mark Hopman
4 Mar 2026
Chief Commercial Officer
Sold on a plan
353
$11.57
$4.08K
Sean Saint
2 Mar 2026
President & CEO
Sell
3,384
$12.36
$41.83K
Stephen Feider
2 Mar 2026
Chief Financial Officer
Sell
1,428
$12.36
$17.65K
Mike Mensinger
2 Mar 2026
Chief Product Officer
Sell
1,064
$12.36
$13.15K
Steven Jon Russell
2 Mar 2026
Chief Medical Officer
Sell
1,026
$12.36
$12.68K
Mark Hopman
2 Mar 2026
Chief Commercial Officer
Sell
834
$12.36
$10.31K
Mike Mensinger
6 Jan 2026
Chief Product Officer
Sold on a plan
2,200
$30.10
$66.22K
Stephen Feider
2 Jan 2026
Chief Financial Officer
Sold after exercise
20,000
$29.53
$590.68K
Mike Mensinger
2 Jan 2026
Chief Product Officer
Sold on a plan
600
$30.20
$18.12K
Mike Mensinger
2 Jan 2026
Chief Product Officer
Sold on a plan
7,200
$29.56
$212.83K
Mark Hopman
4 Dec 2025
Chief Commercial Officer
Sold on a plan
2,061
$30.66
$63.19K
Sean Saint
2 Dec 2025
President & CEO
Sell
3,278
$29.34
$96.16K
Stephen Feider
2 Dec 2025
Chief Financial Officer
Sell
1,427
$29.34
$41.86K
Mike Mensinger
2 Dec 2025
Chief Product Officer
Sell
1,063
$29.34
$31.18K
Steven Jon Russell
2 Dec 2025
Chief Medical Officer
Sell
1,025
$29.34
$30.07K
Mark Hopman
2 Dec 2025
Chief Commercial Officer
Sold on a plan
856
$29.34
$25.11K
Maria Palasis
1 Dec 2025
Director
Sold on a plan
500
$29.96
$14.98K
Maria Palasis
1 Dec 2025
Director
Sold on a plan
906
$29.33
$26.57K
Adam Lezack
1 Dec 2025
Director
Sold on a plan
500
$29.91
$14.96K
Adam Lezack
1 Dec 2025
Director
Sold on a plan
906
$29.35
$26.59K

What was left out

Form 4 filings counted 54
Amendments (4/A) skipped 7
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 26
Sales straight out of an exercise 3
Sales at will 21
Transactions with no price 0
Shares from compensation/vesting 957,777
History held since 31 Jan 2025